UBS analyst Michael Goldsmith raised the firm’s price target on Healthcare Realty Trust (HR) to $20 from $18 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust price target raised to $22 from $20 at Scotiabank
- Healthcare Realty Trust Issues Exchangeable Notes to Bolster Capital
- Healthcare Realty Trust price target raised to $21 from $19 at Citi
- Healthcare Realty Trust Plans $500 Million Exchangeable Notes Offering
- Healthcare Realty Trust price target raised to $22 from $21 at Cantor Fitzgerald